Invention Grant
- Patent Title: Cocrystal
-
Application No.: US17131024Application Date: 2020-12-22
-
Publication No.: US12024512B2Publication Date: 2024-07-02
- Inventor: Kentaro Iwata , Yukihiro Ikeda
- Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Applicant Address: JP Osaka
- Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
- Current Assignee Address: JP Osaka
- Agency: Casimir Jones, SC
- Agent Jeffrey W. Childers
- Priority: JP 16017099 2016.02.01
- Main IPC: C07D471/04
- IPC: C07D471/04

Abstract:
Improving the solubility of an organic compound. A cocrystal of (1) 6-ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-1-methyl-4-oxo-5-(2-oxo-2-phenylethyl)-3-(2,2,2-trifluoroethoxy)-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide and (2) L-malic acid or L-tartaric acid.
Public/Granted literature
- US20210115039A1 COCRYSTAL Public/Granted day:2021-04-22
Information query